Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Dose Titration in RA (RASTS)
NCT01717859Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2014
- Primary completion
- Apr 2017
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by University of California, Los Angeles. Started Sep 2014; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01717859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717859.